CFR-PEEK Pedicle Screw Instrumentation for Spinal Neoplasms: A Single Center Experience on Safety and Efficacy.

CFR-PEEK CFRP carbon reinforced polyethyl-ether-ether-ketone neuro-oncology spinal metastases spinal primary bone tumors

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
27 Oct 2022
Historique:
received: 10 09 2022
revised: 16 10 2022
accepted: 26 10 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 12 11 2022
Statut: epublish

Résumé

(1) Background: Surgery for spinal metastases has gained a decisive role in modern oncological treatment. Recently, carbon-fiber-reinforced (CFR) polyethyl-ether-ether-ketone (PEEK) pedicle screw systems were introduced, reducing artifacts on imaging and showing less perturbation effects on photon radiation. Preliminary clinical experience with CFR-PEEK implants for spinal metastases exists. The aim of this monocentric study is to report on the safety and efficacy of CFR-PEEK pedicle screw systems for spinal neoplasms in a large cohort of consecutive patients. (2) Methods: We retrospectively analyzed prospectively the collected data of consecutive patients being operated on from 1 August 2015 to 31 October 2021 using a CFR-PEEK pedicle screw system for posterior stabilization because of spinal metastases or primary bone tumors of the spine. (3) Results: We included 321 patients of a mean age of 65 ± 13 years. On average, 5 ± 2 levels were instrumented. Anterior reconstruction was performed in 121 (37.7%) patients. Intraoperative complications were documented in 30 (9.3%) patients. Revision surgery for postoperative complications was necessary in 55 (17.1%) patients. Implant-related complications, such as intraoperative screw breakage (3.4%) and screw loosening (2.2%), were rare. (4) Conclusions: CFR-PEEK is a safe and efficient alternative to titanium for oncological spinal instrumentation, with low complication and revision rates in routine use and with the advantage of its radiolucency.

Identifiants

pubmed: 36358693
pii: cancers14215275
doi: 10.3390/cancers14215275
pmc: PMC9658073
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Int Orthop. 2007 Apr;31(2):259-64
pubmed: 16783550
Eur Spine J. 2018 Apr;27(4):874-881
pubmed: 28815357
Sci Rep. 2021 Apr 12;11(1):7988
pubmed: 33846484
Neurosurg Rev. 2021 Aug;44(4):2163-2170
pubmed: 32930911
World Neurosurg. 2021 Jul;151:e495-e506
pubmed: 33905911
Sci Rep. 2021 Jan 28;11(1):2414
pubmed: 33510239
Lancet. 2005 Aug 20-26;366(9486):643-8
pubmed: 16112300
Neurosurg Focus. 2021 May;50(5):E13
pubmed: 33932921
Eur Spine J. 2018 Aug;27(8):1775-1784
pubmed: 29497852
World Neurosurg. 2021 Oct;154:e536-e546
pubmed: 34339894
Adv Orthop. 2020 Jun 09;2020:4796136
pubmed: 32566313
Eur Spine J. 2021 Dec;30(12):3720-3730
pubmed: 34519911
Acta Neurochir (Wien). 1990;107(1-2):37-43
pubmed: 2096606
Sci Rep. 2020 Sep 30;10(1):16094
pubmed: 32999385
Dtsch Arztebl Int. 2011 Feb;108(5):71-9; quiz 80
pubmed: 21311714
Curr Oncol. 2021 Oct 02;28(5):3891-3899
pubmed: 34677250
J Clin Neurosci. 2020 May;75:106-111
pubmed: 32173153
J Neurosurg Spine. 2010 Aug;13(2):144-57
pubmed: 20672949
Brain Spine. 2022 Feb 26;2:100875
pubmed: 36248120
J Bone Oncol. 2022 Jul 09;35:100446
pubmed: 35860387
Acta Neurochir (Wien). 2020 Apr;162(4):943-950
pubmed: 31953690
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Neurosurg Focus. 2021 May;50(5):E7
pubmed: 33932937
World Neurosurg. 2017 Sep;105:294-301
pubmed: 28478252
Cancers (Basel). 2022 Apr 30;14(9):
pubmed: 35565376
World Neurosurg. 2021 Apr;148:e264-e274
pubmed: 33418123
Clin Spine Surg. 2017 Feb;30(1):4-13
pubmed: 27984252
J Clin Oncol. 2016 Sep 1;34(25):3054-61
pubmed: 27400936
J Appl Clin Med Phys. 2017 Mar;18(2):62-68
pubmed: 28300369
Spine (Phila Pa 1976). 1990 Jan;15(1):1-4
pubmed: 2326692
J Clin Oncol. 2016 Jan 20;34(3):268-76
pubmed: 26598751
Phys Med Biol. 2017 Apr 21;62(8):R49-R80
pubmed: 28323641

Auteurs

Ann-Kathrin Joerger (AK)

Department of Neurosurgery, Klinikum Rechts der Isar, Technical University, 81675 Munich, Germany.

Sebastian Seitz (S)

Department of Neurosurgery, Klinikum Rechts der Isar, Technical University, 81675 Munich, Germany.

Nicole Lange (N)

Department of Neurosurgery, Klinikum Rechts der Isar, Technical University, 81675 Munich, Germany.

Amir K Aftahy (AK)

Department of Neurosurgery, Klinikum Rechts der Isar, Technical University, 81675 Munich, Germany.

Arthur Wagner (A)

Department of Neurosurgery, Klinikum Rechts der Isar, Technical University, 81675 Munich, Germany.

Yu-Mi Ryang (YM)

Department of Neurosurgery, Helios Klinikum Berlin-Buch, 13125 Berlin-Buch, Germany.

Denise Bernhardt (D)

Department of Radiooncology, Klinikum Rechts der Isar, Technical University, 81675 Munich, Germany.

Stephanie E Combs (SE)

Department of Radiooncology, Klinikum Rechts der Isar, Technical University, 81675 Munich, Germany.

Maria Wostrack (M)

Department of Neurosurgery, Klinikum Rechts der Isar, Technical University, 81675 Munich, Germany.

Jens Gempt (J)

Department of Neurosurgery, Klinikum Rechts der Isar, Technical University, 81675 Munich, Germany.

Bernhard Meyer (B)

Department of Neurosurgery, Klinikum Rechts der Isar, Technical University, 81675 Munich, Germany.

Classifications MeSH